3-[(4-methylphenyl)amino]indol-2-one; CHEMBL571380; (3E)-3-[(4-methylphenyl)imino]-1,3-dihydro-2H-indol-2-one; MLS001181915; SMR000567637; (3Z)-3-[(4-Methylphenyl)imino]-1,3-dihydro-2H-indol-2-one; NSC298520; Oprea1_142688; CBDivE_000601; 3-(p-toluidino)indol-2-one; cid_326728; SCHEMBL12584950; SCHEMBL16445154; BDBM66793; CTK1D6594; 3-(4-methylanilino)-2-indolone; DTXSID80316010; HMS1608I09; ALBB-016883; 3-(p-Tolylamino)-2H-indol-2-one; BDBM50301379; MFCD00443382; SBB083405; STK725176; ZINC12447517; (E)-3-(p-Tolylimino)indolin-2-one; 3-(4-Methylphenylimino)indolin-2-one; AKOS001267965; AKOS001586934; AKOS030699073; CCG-277051; MCULE-9286673329; NSC-298520; (E/Z)-3-(p-tolylimino)indolin-2-one; 3-p-Tolylimino-1,3-dihydro-indol-2-one; Indol-2(3H)-one, 3-(4-tolylimino)-; DS-014008; ST4032793; EU-0067031; R3020; BIM-0207653.0001; MLS-0326244.0001; 3-[(4-methylphenyl)imino]-1,3-dihydro-2H-indol-2-one; 3-[(4-methylphenyl)azamethylene]-1H-benzo[d]azolin-2-one; Indol-2(2H)-one, 1,3-dihydro-3[(4-methylphenyl)imino]-; 3-[(4-methylphenyl)azamethylene]-1H-benzo[d]azolidin-2-one; (3Z)-3-[(4-Methylphenyl)imino]-1,3-dihydro-2H-indol-2-one #; 2H-indol-2-one, 1,3-dihydro-3-[(4-methylphenyl)imino]-, (3E)-